You are visiting United Kingdom
If this is incorrect,
How does M&A factor into the growth of compounders companies? Being a “marathon runner” requires more than just a venerable age (an average of 126 years in our portfolio). Over time, these companies have used their resilience and built up competitive moats yielding exceptional free cash and healthy balance sheets. By leveraging these elements, compounders seize on M&A opportunities to fuel future organic growth.
"The Long & Winding Road", the Beatles' 1969 anthem, seems appropriate for a world that has long been seeking ways to address environmental protections and preservation. Public excitement about carbon neutrality seems to have waned in the years since COP26, the 2021 United Nations’ summit on climate change. The reality, though, is that renewables are becoming more prevalent, less pricey and more prominent – positioning many countries on a path towards steadily declining emissions.
Discover what's happening in the US market beyond the spotlight of the Magnificent 7. These big tech companies may dominate their respective industries, but the US market is not entirely devoid of opportunities for new entrants. The key lies in understanding that not all growth is created equal. Success is not just about entering the market, but about continuously evolving to meet the changing needs of consumers.
Why and how do some companies keep getting better with age? European Equity Analysts/Portfolio Managers James Hanford and Alistair Wittet delve into Novo Nordisk and L’Orèal – each over a century – to see what can be gleaned from their lengthy histories. They also touch on the predictive power of Lindy’s Law and advances in artificial intelligence that can help investors gauge a company’s potential longevity.
Salmon farmers are facing a tough upstream battle to create businesses that align with ESG principles. ESG Analyst and Portfolio Manager Petra Daroczi details some of the pros and cons of salmon fishing with a focus on one of our portfolio companies: Bakkafrost.
2022 will arguably go down in history as the year when inflation returned while bonds failed to offer investors in balanced funds the much-needed protection and diversification from the decline in equities that they used to provide.
We believe that another option is to look for a different approach to investing while adhering to a similar risk-return profile to a balanced portfolio. To cushion the downside risk of a pure equity allocation, an investor may consider the need to add a hedging overlay to their portfolio.